PROVIDER PROFILE · NPI 1205830890

Kenneth AlpernMD

PRACTICERAHIMI INCSee all providers at this practice →

DermatologyFullerton, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

200

Unique beneficiaries

—

Total services

415

Distinct HCPCS

Medicare payment

$13K

Peer benchmark

Total Medicare services vs. 1,546 Dermatology providers in CA — bottom quintile (cohort median 2,504).

PRESCRIBING · PART D · 2024

Total Rx claims

3,684

Beneficiaries

—

Total drug cost

$1.9M

Distinct drugs

Brand share

15.6%

Top prescribed drugs

Fluocinonide351 claims

Clobetasol Propionate339 claims

Triamcinolone Acetonide306 claims

Mupirocin304 claims

Doxycycline Monohydrate281 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$11K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$10K

Food and Beverage$869

Education$99

REFERRAL NETWORK

Where Kenneth Alpern's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · San Diego, CA	20	36
Laboratory Corporation Of America Clinical Laboratory · Los Angeles, CA	17	23

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history